APG Asset Management N.V. Raises Holdings in Colgate-Palmolive (NYSE:CL)

APG Asset Management N.V. lifted its stake in shares of Colgate-Palmolive (NYSE:CLFree Report) by 64.3% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,251,422 shares of the company’s stock after acquiring an additional 489,977 shares during the period. APG Asset Management N.V.’s holdings in Colgate-Palmolive were worth $113,308,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CL. Vanguard Group Inc. lifted its stake in shares of Colgate-Palmolive by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock valued at $6,368,378,000 after purchasing an additional 416,853 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in Colgate-Palmolive by 27.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock valued at $3,698,096,000 after buying an additional 8,933,912 shares during the period. Massachusetts Financial Services Co. MA lifted its position in Colgate-Palmolive by 40.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after buying an additional 2,593,313 shares during the last quarter. GUARDCAP ASSET MANAGEMENT Ltd boosted its stake in Colgate-Palmolive by 4.1% during the first quarter. GUARDCAP ASSET MANAGEMENT Ltd now owns 6,987,454 shares of the company’s stock worth $629,220,000 after buying an additional 278,150 shares during the period. Finally, Acadian Asset Management LLC increased its position in shares of Colgate-Palmolive by 108.4% during the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after acquiring an additional 2,955,442 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.7 %

Shares of NYSE:CL opened at $103.05 on Friday. The firm has a 50 day simple moving average of $103.05 and a 200-day simple moving average of $96.16. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $109.30. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. The company has a market capitalization of $84.55 billion, a PE ratio of 32.61, a P/E/G ratio of 3.62 and a beta of 0.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. Colgate-Palmolive’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.77 earnings per share. On average, equities analysts predict that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s payout ratio is currently 63.29%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on CL shares. HSBC reissued a “hold” rating on shares of Colgate-Palmolive in a research note on Friday, July 26th. Hsbc Global Res cut shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a report on Friday, July 26th. Citigroup upped their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. Finally, Bank of America increased their price objective on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average price target of $104.74.

Read Our Latest Stock Report on CL

Insider Transactions at Colgate-Palmolive

In other news, insider Panagiotis Tsourapas sold 14,794 shares of the company’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the completion of the sale, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares in the company, valued at approximately $529,729.24. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.